[FATE] QoQ Quarter Result on 31-Dec-2018 [#Q4]

Stock
[FATE] Fate Therapeutics, Inc.
Announcement Date
05-Mar-2019
Financial Year
2018
Quarter
31-Dec-2018 [#Q4]
Profit Trend
QoQ- 4.50%
YoY- -28.25%
Quarter Report
FATE's Result
FATE's Financial Summary
View:
Show?
Quarter Result
30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 CAGR
Revenue 2,429 2,817 2,632 1,661 1,026 1,027 1,026 77.53%
PBT -26,609 -23,478 -19,760 -16,027 -16,782 -19,654 -14,135 52.40%
Tax 910 1,015 1,091 817 339 376 331 96.12%
NP -26,609 -23,478 -19,760 -16,027 -16,782 -19,654 -14,135 52.40%
Tax Rate - - - - - - - -
Total Cost 29,038 26,295 22,392 17,688 17,808 20,681 15,161 54.16%
Ratio Analysis
30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 CAGR
NP Margin -1,095.47 -833.44 -750.76 -964.90 -1,635.67 -1,913.73 -1,377.68 -14.15%
Per Share
30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 CAGR
EPS -0.40 -0.36 -0.30 -0.25 -0.31 -0.37 -0.27 29.92%
EPS Diluted -0.40 -0.36 -0.30 -0.25 -0.31 -0.37 -0.27 29.92%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.